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The management of vesicoureteral reflux is a mainstay of pediatric urology. This management however,
has evolved considerably throughout the years due to a dynamic understanding of both pathology and the
relationship between surgical and medical therapies. The purpose of this article is to provide the reader
with a historical perspective on management and delineate how its past has shaped current therapies and
guidelines.
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If there was a specialty defined by an anomaly it would have to be that
of pediatric urology and vesicoureteral reflux (VUR). With a recent
meta-analysis demonstrating a prevalence of up to 9% in children
[1], it is easy to imagine that in a typical day in the office of a pediatric
urologist a significant amount of time is spent managing reflux.
That management, however, has evolved considerably throughout∗ Corresponding author.
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ne needs only to consider the changes in our perception of VUR
ince its clinical significance has been realized to appreciate this
volution. The innovations of surgical technique and technological
dvances have been balanced by the use of antibiotic prophylaxis and
on-surgical management. The purpose of this article is to provide
he reader with a historical perspective on management and delineate
ow its past has shaped current therapies and guidelines.
n receipt of the American Academy of Pediatrics Medal in Urol-
gy in 2003, Barry O’Donnell listed the following concepts which
ad been mainstays of VUR management and have since become
allacies:
. Vesicoureteral reflux is rare.
. Vesicoureteral reflux is progressive.
















































































































. Grading of reflux is not important.
. Bladder outlet obstruction causes vesicoureteral reflux.
. Vesicoureteral reflux is always bilateral—eventually.
. Vesicoureteral reflux always causes progressive renal disease.
n  the  beginning
he discovery of ureteral anatomy and the function of the
reterovesical junction can be seen in the early experiments of
alen, the drawings and discussions of Leonardo da Vinci, and the
issections of John Sampson. Da Vinci postulated an anti-reflux
echanism to prevent urine from returning into the upper tracts [2].
ohn Sampson determined that it was the detrusor backing of the
reter that allowed for one-way urine flow [3]. It was not until the
950s, however, that Hodson and Edwards discovered the associa-
ion of VUR with renal scarring from bacterial infection [4]. This
iscovery was backed by an abundance of research demonstrating an
xponential relationship between number of urinary tract infections,
he grade of reflux and renal scarring. Working within this concept,
here was concern that uncontrolled reflux would eventually lead to
eflux nephropathy and end-stage renal disease.
n 1952, Hutch performed the first antireflux surgery in paraplegic
atients. Dedicated to the investigation of the relationship between
UR and upper tract damage, his procedure paved the way for
ther reimplantation techniques [5]. In 1958, Politano and Lead-
etter introduced a new surgical corrective procedure for VUR:
ntravesical ureteral reimplantation. Compared to prior surgical
herapies which aimed to reduce resistance at the bladder neck,
reteral reimplantation negated the concept that bladder outlet resis-
ance was the major cause of reflux [6]. While variations in the
eadbetter–Politano reimplantation have been developed, its basic
echanism of surgical correction remains. As a reliable and repro-
ucible procedure when performed by an experienced surgeon,
reteral reimplantation became the gold standard therapy for treat-
ent of VUR. We were now given the opportunity to diagnosis and
asily correct a condition which threatened the functionality of the
idney. Healthy children with reflux underwent surgical correction
nd ureteral reimplantation was a principal tool in the repertoire of
he pediatric urologist.
hanging  gears
reteral reimplantation was hailed as paramount in the management
f VUR for nearly 20 years until the work of Edwards et al. [7]. In
977, they reported high rates of spontaneous resolution of reflux
71%) on low dose continuous antibiotic prophylaxis (CAP). It was
oted that more severe reflux was less likely to resolve, but their
ork also highlighted that while on CAP, there was a decreased
hance of developing new renal scars [7]. The idea of surveillance
n CAP was also supported by the work of O’Donnell et al. [8]
nd Lenaghan [9]. These groups demonstrated that children with
UR on continuous antibiotics had less renal damage than those
ho received episodic treatment for urinary tract infections. Con-
inuous antibiotic prophylaxis for “refluxers” became customary,
ith maintenance of therapy until resolution or surgical fixation.rolonged antibiotic prophylaxis in children soon became a topic
f debate. The paucity of randomized controlled trials challenged
he concept that even low grade reflux required continuous antibi-
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uch as the International Reflux Study and the Birmingham Study
ompared children on antibiotic therapy with those that underwent
urgical correction. A “non-treatment” arm was not part of the study
esign due to the notion that non-treatment placed the patient with
eflux at significant risk and endangered patient safety. Clinical trials
egan to target the safety of stopping antibiotic prophylaxis in select
atient populations to determine the development of UTI and/or
enal scarring.
here have been 8 randomized controlled trials (RTC) compar-
ng CAP to no prophylaxis in patients with VUR. Half of the
rails determined that prophylaxis was not helpful (and in some
ases harmful), while the other half demonstrated that continu-
us prophylaxis reduced the risk of symptomatic or febrile UTIs
y up to 37%. With an even split, the decisions that pediatric
rologists face when managing patients with VUR are complex
nd not always clear. Upon closer examination of these RTCs,
t is evident that the study populations were quite different. In
hose 4/8 studies which indicated no benefit to continuous pro-
hylaxis, the study populations were predominantly low grade
efluxers, commonly but not exclusively, without consideration of
ladder and bowel dysfunction. Although the option of foregoing
ntibiotic prophylaxis in patients with low risk reflux has clearly
een demonstrated, further investigation into this area is indicated
nd careful discussion with parents about the options is crucial.
ne assumption that is often made in these studies is that low
rade  reflux is equivalent to low risk  VUR and that high grade
s equivalent to high risk  VUR, which is a dangerous oversimplifi-
ation.
nnovations
n addition to the management of vesicoureteral reflux, the timing
f diagnosis has also evolved over the years. The 1980s brought
bout the routine use of prenatal imaging. Prior to this time, vesi-
oureteral reflux was primarily identified after the onset of a febrile
rinary tract infection. Prenatal ultrasound recognized upper tract
ilation with or without renal dysplasia in asymptomatic patients,
eading to postnatal investigation and possible identification of VUR
rior to development of a symptomatic UTI and acquired renal
amage. In 1993 the Society for Fetal Urology (SFU) issued recom-
endations for postnatal investigation of antenatal hydronephrosis
n order to identify and treat clinically significant pathology prior
o development of symptoms. In order to standardize terminology
nd guidelines for postnatal investigation, Nguyen et al. proposed a
ultidisciplinary consensus on antenatal upper tract dilation [10].
long with the use of prenatal ultrasound, the 1980s was also sig-
ificant for the introduction of a standardized grading system by
he International Reflux Study Committee. Voiding cystourethro-
ram (VCUG) allowed for demonstration of reflux on imaging
tudies. The guidelines provided by the SFU and further clas-
ified by Nguyen, et al. proposed imaging studies for patients
ho present with certain criteria. The International Reflux Study
ommittee delineated five grades of reflux based on the VCUG,
nd discussions of management became more specific. Reflux
rading allowed separation into lower and higher grades, pro-
oting investigation into varying therapy depending on the gradef reflux. That being said, assessing risk in vesicoureteral reflux
sing reflux grade alone offers a limited, and often skewed assess-
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When discussing vesicoureteral reflux, one must be aware of its
association with bowel and bladder dysfunction. Initial surgical
treatment for VUR attempted correction of intravesical pressure
by approaching the bladder neck. Following establishment of the
Leadbetter–Politano reimplantation, focus transitioned more specif-
ically to the ureterovesical junction. It was only later that we began to
appreciate the complex relationship between bladder neck, bladder,
and incompetent UVJ. The International Reflux Study’s European
branch identified a population of children with “bladder ureteral
dysfunction”, who had increased risk of urinary tract infections,
persistent reflux, and variability in reflux grading between imag-
ing studies [11]. Numerous reports have confirmed bladder bowel
dysfunction as an independent predictor of low reflux resolution
rates and increased breakthrough infections. With our evolving
understanding of bladder bowel dysfunction being possibly both
a radiologic, as well as a behavioral abnormality, approach to treat-
ment has changed. Management of patients with bladder bowel
dysfunction incorporates behavioral modification but also poses a
unique challenge in predicting outcomes. The most recent AUA
guidelines on VUR emphasize the importance of the management
of bladder and bowel dysfunction in children with VUR. These
recommendations aim to reduce the risk of upper tract infections
and renal scarring, maximize spontaneous resolution, as well as
increase success rates of corrective procedures [12]. It is clear
that this interplay will become a key component in future discus-
sions.
At the turn of the century, pediatric urologists followed suit in
the general trend of surgery, attempting to incorporate minimally
invasive surgical techniques. Although endoscopic injections for
treatment of VUR was introduced in the 1980s, the procedure
rapidly gained popularity in the United States when the FDA
approved dextranomer/hyaluronic acid (Deflux) in 2001. Lendvay
et al. investigated the evolving trends in the treatment of VUR with
the availability of endoscopic therapy. Their study demonstrated a
143% increase in the number of VUR procedures per institution per
year between 2001 and 2004 in children’s hospitals in the United
States [13]. These results were corroborated by Caleb and Copp
et al. who showed that between 2002 and 2006 the treatment of
reflux using early endoscopic intervention almost doubled, due to
endoscopic correction [14]. This trend, however, has not been sus-
tained and, in fact, a significant decrease in the use of endoscopic
correction in the United States was seen from 2006 to 2011 [15].
Most pediatric urologists still struggle with the role of endoscopic
correction: does it replace ureteral reimplantation, is it a substitute
for antibiotic prophylaxis, or is it a temporizing measure to allow
children to get through a period of time when they are susceptible
to UTIs?
Future
With the development of endoscopic and minimally invasive surgi-
cal interventions, changes in antibiotic prophylaxis regimens, and
the latest assessment of the safety and success of traditional ureteral
reimplant, several sets of guidelines have been issued and updated.
Management of VUR continues to be a dynamic subject, often with
large variations in practice patterns between early intervention vs.
observation only. The future is replete with potential for research.
Future study is likely to further stratify VUR patients into those who
are at high risk for renal damage versus those with low risk, and will
allow us to better individualize and manage care.
[
3
onflict  of  interest
he authors declare no conflict of interest.
ource  of  funding





anuscipt editor and author.
. A. Koyle.
anuscipt editor and author.
. A. Caldamone.
anuscipt editor and author.
eferences
[1] Sargent AM. Opinion. Pediatr Radiol 2000;30(9):587–93.
[2] Schultheiss D, Grünewald V, Jonas U. Urodynamics in the anatom-
ical work of Leonardo da Vinci (1452–1519). World J Urol
1999;17(3):137–43.
[3] Shattuck GB, editor. Boston Med Surg J 1904.
[4] Hodson CJ, Edwards D. Chronic pyelonephritis and vesico-ureteric
reflex. Clin Radiol 1960;11:219–31.
[5] Hutch JA. Vesico-ureteral reflux in the paraplegic: cause and correction.
J Urol 1952;68(2):457–69.
[6] Politano VA, Leadbetter WF. An operative technique for the correction
of vesicoureteral reflux. J Urol 2002;167(3):1415–21.
[7] Edwards D, Normand IC, Prescod N, Smellie JM. Disappearance of
vesicoureteric reflux during long-term prophylaxis of urinary tract
infection in children. Br Med J 1977;2(6082):285–8.
[8] O’Donnell B, Moloney MA, Lynch V. Vesico-ureteric reflux in infants
and children: results of supervision, chemotherapy and surgery. Br J
Urol 1969;41(1):6–13.
[9] Lenaghan D. Results of conservative treatment of vesicoureteric reflux
in children. Br J Urol 1970;42(6):736.
10] Nguyen HT, Benson C, Bromley B, Campbell J, Chow J, Coleman B,
et al. Multidisciplinary consensus on the classification of prenatal and
postnatal urinary tract dilation (UTD classification system). J Pediatr
Urol 2014;10(6):982–98.
11] Olbing H, Hirche H, Koskimies O, Lax H, Seppänen U, Smellie
JM, et al. Renal growth in children with severe vesicoureteral reflux:
10-year prospective study of medical and surgical treatment: the
International Reflux Study in Children (European branch). Radiology
2000;216(3):731–7.
12] Craig Craig A, Skoog S, Arant B, Copp H, Elder J, Hudson R, et al.
Management and screening of primary vesicoureteral reflux in children:
AUA guideline. American Urological Association; 2010.13] Lendvay TS, Sorensen M, Cowan C, Joyner B, Mitchell M, Grady
R. The evolution of vesicoureteral reflux management in the era of
dextranomer/hyaluronic acid copolymer: a pediatric health information




14] Nelson CP, Copp H, Lai J, Saigal C. Is availability of endoscopy
changing initial management of vesicoureteral reflux? J Urol
2009;182(3):1152–7.
[
K.N. DeCotiis et al.15] Herbst KW, Corbett S, Lendvay T, Caldamone A. Recent trends in
the surgical management of primary vesicoureteral reflux in the era of
dextranomer/hyaluronic acid. J Urol 2014;191(Suppl. 5):1628–33.
